PRGO Insider Trading

Insider Ownership Percentage: 0.70%
Insider Buying (Last 12 Months): $27,900.00
Insider Selling (Last 12 Months): $2,123,496.66

Perrigo Insider Trading History Chart

This chart shows the insider buying and selling history at Perrigo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$214ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5M$0$5MTotal Insider BuyingTotal Insider Selling

Perrigo Share Price & Price History

Current Price: $27.25
Price Change: Price Decrease of -0.49 (-1.77%)
As of 03/25/2025 04:58 PM ET

This chart shows the closing price history over time for PRGO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$27.25Closing price on 03/25/25:

SEC Filings (Institutional Ownership Changes) for Perrigo (NYSE:PRGO)

95.91% of Perrigo stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PRGO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$438Mbought$187MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$400M-$200M$0$200M$400MTotal InflowsTotal Outflows
Perrigo logo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More on Perrigo

Today's Range

Now: $27.25
Low: $27.17
High: $27.89

50 Day Range

MA: $25.87
Low: $23.53
High: $29.50

52 Week Range

Now: $27.25
Low: $23.14
High: $33.46

Volume

1,164,595 shs

Average Volume

1,433,553 shs

Market Capitalization

$3.72 billion

P/E Ratio

N/A

Dividend Yield

4.07%

Beta

0.48

Who are the company insiders with the largest holdings of Perrigo?

Perrigo's top insider shareholders include:
  1. Svend Andersen (EVP)
  2. Ronald Craig Janish (EVP)
  3. Geoffrey M Parker (Director)
  4. Robert Willis (EVP)
  5. Patrick Lockwood-Taylor (CEO)
  6. Alison Ives (EVP)
  7. Eduardo Guarita Bezerra (CFO)
  8. Katherine C Doyle (Director)
  9. Jeffrey B Kindler (Director)
  10. Murray S Kessler (CEO)
Learn More about top insider investors at Perrigo.

Who are the major institutional investors of Perrigo?

Perrigo's top institutional shareholders include:
  1. Vanguard Group Inc. — 10.90%
  2. Price T Rowe Associates Inc. MD — 5.75%
  3. Dimensional Fund Advisors LP — 5.12%
  4. Deprince Race & Zollo Inc. — 3.34%
  5. Cooke & Bieler LP — 2.62%
  6. Thompson Siegel & Walmsley LLC — 2.09%
Learn More about top institutional investors of Perrigo stock.

Which institutional investors are selling Perrigo stock?

During the previous quarter, PRGO stock was sold by these institutional investors:
  1. DAVENPORT & Co LLC
  2. Millennium Management LLC
  3. Crestline Management LP
  4. AQR Capital Management LLC
  5. Nuveen Asset Management LLC
  6. JPMorgan Chase & Co.
  7. First Trust Advisors LP
  8. Cutter Capital Management LP
During the previous year, company insiders that have sold Perrigo company stock include:
  1. Svend Andersen (EVP)
  2. Ronald Craig Janish (EVP)
  3. Geoffrey M Parker (Director)
  4. Robert Willis (EVP)
Learn More investors selling Perrigo stock.

Which institutional investors are buying Perrigo stock?

In the last quarter, PRGO stock was purchased by institutional investors including:
  1. Price T Rowe Associates Inc. MD
  2. Norges Bank
  3. Ion Asset Management Ltd.
  4. BW Gestao de Investimentos Ltda.
  5. Boone Capital Management LLC
  6. Bahl & Gaynor Inc.
  7. Vestal Point Capital LP
  8. Access Investment Management LLC
Within the last year, these company insiders have bought Perrigo stock:
  1. Svend Andersen (EVP)
  2. Ronald Craig Janish (EVP)
  3. Geoffrey M Parker (Director)
  4. Robert Willis (EVP)
  5. Patrick Lockwood-Taylor (CEO)
  6. Alison Ives (EVP)
Learn More investors buying Perrigo stock.